Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism MC3R agonists(Melanocortin receptor 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Courage Therapeutics, Inc.Startup |
Active Organization Courage Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anorexia | Preclinical | US | Courage Therapeutics, Inc.Startup | 01 Nov 2024 |
Cachexia | Preclinical | US | Courage Therapeutics, Inc.Startup | 01 Nov 2024 |
Infertility | Preclinical | US | Courage Therapeutics, Inc.Startup | 01 Nov 2024 |
Sarcopenia | Preclinical | US | Courage Therapeutics, Inc.Startup | 01 Nov 2024 |